Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
Table 3
Hair disorders in COVID-19 patients.
Clinical manifestations and laboratory investigations: Number/total (%)
Increased hair shedding
No increased hair shedding
Crude OR (95% CI)
Adjusted OR (95% CI)
value
Severity of COVID-19 ()
22 (23.7)
71 (76.3)
Asymptomatic-mild ()
11 (16.4)
56 (83.6)
3.7 (1.4, 10.3)
5.8 (1.8, 18.9)
0.008
Moderate-severe-critical state ()
11 (42.3)
15 (57.7)
Gender
Female ()
14 (35.9)
25 (64.1)
3.2 (1.2, 8.7)
5.0 (1.6, 15.9)
0.018
Male ()
8 (14.8)
46 (85.2)
Age at onset: (years)
0.339
Laboratory investigations
Leukopenia ()
3 (12.0)
22 (88.0)
0.222
Leukocytosis ()
2 (40.0)
3 (60.0)
Abnormal liver function test ()
6 (35.3)
11 (64.7)
0.209
Elevated C-reactive protein ()
12 (34.3)
23 (65.7)
0.091
The data are expressed as odds ratio with 95% confidence interval. Multivariable odds ratio was calculated by stepwise logistic regression. OR: odds ratio; CI: confidence interval.
